Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Receive case studies from Merck Serono, MHRA, Teva plus many more at Biosimilars and BiobettersSMi's Biosimilars and Biobetters conference, taking place on 30 September - 1 October 2015 in London, will address pharmacovigilance of biosimilars, patent litigation, market access, product commercialisation barriers and global market developments.
By: SMi Group Who Will You Meet? Network with Confirmed Attendees from Organisations Including: AbbVie, Alston & Bird LLP, Anteris Medical GmbH, Arnold & Porter LLP, Boehringer Ingelheim, Bristows LLP, Cinfa Biotech GmbH, Ecole Normale Supérieure de Cachan, Eppendorf, Fresenius Kabi, GfK, Grifols, Harvest Moon Pharmaceuticals, IMS Health UK, Italfarmaco S.p.A., Kantar Health, Kinesys Consulting, Merck Serono, MHRA, Mundipharma, Norwegian Medicines Agency, Newcastle University, SAI MedPartners, Sandoz International GmbH, Sanofi, Selecta Biosciences, SGS Life Science Services, SGS M-Scan Ltd, Teva, University of Basel, Venner Shipley LLP plus many more... Speaker Panel includes: • Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals USA, Inc. • Shahin Kauser, Senior Scientific Assessor, MHRA • Chris Teale, Vice President Europe, GfK NOP Ltd • Bracha Timan, Director, Israel Site Head, Global Bioassays & Technology, Global R&D, Teva • Takashi Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences • Karsten Roth, Director Clinical Operations, Cinfa Biotech GmbH • Alan Sheppard, Principal, Global Generics and Biosimilars, IMS Health • Steinar Madsen, Medical Director, Norwegian Medicines Agency To view the full speaker line-up and complete two-day conference programme, visit http://www.smi- Plus, don't forget the two interactive conference workshops: A: Assessing the Regulatory Framework for Europe and the US – Developing Future Biologics | Led by: Lincoln Tsung, Daniel Kracov, Jennifer Sklenar, Partners, Arnold & Porter (UK) LLP 1:00pm - 5.30pm, 29 September 2015 B: Biosimilars - Understanding the Regulatory Processes and the Commercial Realities | Led by: Peter Wittner, Senior Consultant, Interpharm Consultancy 8:30am - 12.30pm, 2nd October 2015 End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|